English
简体中文
Total: £ 56.28
Published Date: 2025-06-25 | Pages: 160 | Tables: 153 | Medical Care
In 2024, the global market size of Medical Isotopes was estimated to be worth US$ 836 million and is forecast to reach approximately US$ 1074 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a "cold" process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.
North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Isotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Isotopes.
The Medical Isotopes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Isotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Isotopes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science
Segment by Type
Stable Isotopes
Radioisotopes
Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Medical Isotopes in global and regional level.
Chapter 3: Detailed analysis of Medical Isotopes company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Isotopes revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Medical Isotopes Product Introduction
1.2 Market by Type
1.2.1 Global Medical Isotopes Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Stable Isotopes
1.2.3 Radioisotopes
1.3 Market by Application
1.3.1 Global Medical Isotopes Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Isotopes Market Size Estimates and Forecasts
2.2 Medical Isotopes Market Size by Region: 2024 Versus 2031
2.2.1 Global Medical Isotopes Revenue by Region: 2020-2025
2.2.2 Global Medical Isotopes Revenue Forecast by Region (2026-2031)
2.2.3 Global Medical Isotopes Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Medical Isotopes Revenue by Type (2020-2031)
3.1.2 Global Medical Isotopes Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Medical Isotopes Revenue by Application (2020-2031)
3.2.2 Global Medical Isotopes Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Stable Isotopes of Medical Isotopes Revenue Market Share by Application
3.3.2 Radioisotopes of Medical Isotopes Revenue Market Share by Application
4 Global Medical Isotopes by Company
4.1 Global Medical Isotopes Revenue by Company (2020-2025)
4.2 Global Medical Isotopes Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Medical Isotopes Companies around the World: Ranking by Revenue
4.3.2 Global Medical Isotopes Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Medical Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Medical Isotopes Companies Headquarters & Product Type
4.4.1 Global Medical Isotopes Companies Headquarters
4.4.2 Date of International Companies Enter into Medical Isotopes Market
4.4.3 Global Medical Isotopes Companies Product & Service
4.4.4 Stable Isotopes Revenue Market Share of Medical Isotopes by Company
4.4.5 Radioisotopes Revenue Market Share of Medical Isotopes by Company
4.5 Global Medical Isotopes Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 NRG
5.1.1 NRG Corporation Information
5.1.2 NRG Description, Business Overview
5.1.3 NRG Medical Isotopes Products Offered
5.1.4 NRG Medical Isotopes Revenue and Gross Margin (2020-2025)
5.1.5 NRG Medical Isotopes Revenue by Product in 2024
5.1.6 NRG Medical Isotopes Revenue by Application in 2024
5.1.7 NRG Medical Isotopes Revenue by Geographic Area in 2024
5.1.8 NRG Recent Developments
5.2 NTP Radioisotopes
5.2.1 NTP Radioisotopes Corporation Information
5.2.2 NTP Radioisotopes Description, Business Overview
5.2.3 NTP Radioisotopes Medical Isotopes Products Offered
5.2.4 NTP Radioisotopes Medical Isotopes Revenue and Gross Margin (2020-2025)
5.2.5 NTP Radioisotopes Medical Isotopes Revenue by Product in 2024
5.2.6 NTP Radioisotopes Medical Isotopes Revenue by Application in 2024
5.2.7 NTP Radioisotopes Medical Isotopes Revenue by Geographic Area in 2024
5.2.8 NTP Radioisotopes Recent Developments
5.3 JSC Isotope
5.3.1 JSC Isotope Corporation Information
5.3.2 JSC Isotope Description, Business Overview
5.3.3 JSC Isotope Medical Isotopes Products Offered
5.3.4 JSC Isotope Medical Isotopes Revenue and Gross Margin (2020-2025)
5.3.5 JSC Isotope Medical Isotopes Revenue by Product in 2024
5.3.6 JSC Isotope Medical Isotopes Revenue by Application in 2024
5.3.7 JSC Isotope Medical Isotopes Revenue by Geographic Area in 2024
5.3.8 JSC Isotope Recent Developments
5.4 ANSTO
5.4.1 ANSTO Corporation Information
5.4.2 ANSTO Description, Business Overview
5.4.3 ANSTO Medical Isotopes Products Offered
5.4.4 ANSTO Medical Isotopes Revenue and Gross Margin (2020-2025)
5.4.5 ANSTO Medical Isotopes Revenue by Product in 2024
5.4.6 ANSTO Medical Isotopes Revenue by Application in 2024
5.4.7 ANSTO Medical Isotopes Revenue by Geographic Area in 2024
5.4.8 ANSTO Recent Developments
5.5 IRE
5.5.1 IRE Corporation Information
5.5.2 IRE Description, Business Overview
5.5.3 IRE Medical Isotopes Products Offered
5.5.4 IRE Medical Isotopes Revenue and Gross Margin (2020-2025)
5.5.5 IRE Medical Isotopes Revenue by Product in 2024
5.5.6 IRE Medical Isotopes Revenue by Application in 2024
5.5.7 IRE Medical Isotopes Revenue by Geographic Area in 2024
5.5.8 IRE Recent Developments
5.6 Nordion
5.6.1 Nordion Corporation Information
5.6.2 Nordion Description, Business Overview
5.6.3 Nordion Medical Isotopes Products Offered
5.6.4 Nordion Medical Isotopes Revenue and Gross Margin (2020-2025)
5.6.5 Nordion Medical Isotopes Revenue by Product in 2024
5.6.6 Nordion Medical Isotopes Revenue by Application in 2024
5.6.7 Nordion Medical Isotopes Revenue by Geographic Area in 2024
5.6.8 Nordion Recent Developments
5.7 Curium Pharma
5.7.1 Curium Pharma Corporation Information
5.7.2 Curium Pharma Description, Business Overview
5.7.3 Curium Pharma Medical Isotopes Products Offered
5.7.4 Curium Pharma Medical Isotopes Revenue and Gross Margin (2020-2025)
5.7.5 Curium Pharma Medical Isotopes Revenue by Product in 2024
5.7.6 Curium Pharma Medical Isotopes Revenue by Application in 2024
5.7.7 Curium Pharma Medical Isotopes Revenue by Geographic Area in 2024
5.7.8 Curium Pharma Recent Developments
5.8 Cambridge Isotope Laboratories
5.8.1 Cambridge Isotope Laboratories Corporation Information
5.8.2 Cambridge Isotope Laboratories Description, Business Overview
5.8.3 Cambridge Isotope Laboratories Medical Isotopes Products Offered
5.8.4 Cambridge Isotope Laboratories Medical Isotopes Revenue and Gross Margin (2020-2025)
5.8.5 Cambridge Isotope Laboratories Medical Isotopes Revenue by Product in 2024
5.8.6 Cambridge Isotope Laboratories Medical Isotopes Revenue by Application in 2024
5.8.7 Cambridge Isotope Laboratories Medical Isotopes Revenue by Geographic Area in 2024
5.8.8 Cambridge Isotope Laboratories Recent Developments
5.9 Eckert & Ziegler Strahlen
5.9.1 Eckert & Ziegler Strahlen Corporation Information
5.9.2 Eckert & Ziegler Strahlen Description, Business Overview
5.9.3 Eckert & Ziegler Strahlen Medical Isotopes Products Offered
5.9.4 Eckert & Ziegler Strahlen Medical Isotopes Revenue and Gross Margin (2020-2025)
5.9.5 Eckert & Ziegler Strahlen Medical Isotopes Revenue by Product in 2024
5.9.6 Eckert & Ziegler Strahlen Medical Isotopes Revenue by Application in 2024
5.9.7 Eckert & Ziegler Strahlen Medical Isotopes Revenue by Geographic Area in 2024
5.9.8 Eckert & Ziegler Strahlen Recent Developments
5.10 Polatom
5.10.1 Polatom Corporation Information
5.10.2 Polatom Description, Business Overview
5.10.3 Polatom Medical Isotopes Products Offered
5.10.4 Polatom Medical Isotopes Revenue and Gross Margin (2020-2025)
5.10.5 Polatom Medical Isotopes Revenue by Product in 2024
5.10.6 Polatom Medical Isotopes Revenue by Application in 2024
5.10.7 Polatom Medical Isotopes Revenue by Geographic Area in 2024
5.10.8 Polatom Recent Developments
5.11 Center of Molecular Research
5.11.1 Center of Molecular Research Corporation Information
5.11.2 Center of Molecular Research Description, Business Overview
5.11.3 Center of Molecular Research Medical Isotopes Products Offered
5.11.4 Center of Molecular Research Medical Isotopes Revenue and Gross Margin (2020-2025)
5.11.5 Center of Molecular Research Medical Isotopes Revenue by Product in 2024
5.11.6 Center of Molecular Research Medical Isotopes Revenue by Application in 2024
5.11.7 Center of Molecular Research Medical Isotopes Revenue by Geographic Area in 2024
5.11.8 Center of Molecular Research Recent Developments
5.12 China National Nuclear Corporation
5.12.1 China National Nuclear Corporation Corporation Information
5.12.2 China National Nuclear Corporation Description, Business Overview
5.12.3 China National Nuclear Corporation Medical Isotopes Products Offered
5.12.4 China National Nuclear Corporation Medical Isotopes Revenue and Gross Margin (2020-2025)
5.12.5 China National Nuclear Corporation Medical Isotopes Revenue by Product in 2024
5.12.6 China National Nuclear Corporation Medical Isotopes Revenue by Application in 2024
5.12.7 China National Nuclear Corporation Medical Isotopes Revenue by Geographic Area in 2024
5.12.8 China National Nuclear Corporation Recent Developments
5.13 Urenco
5.13.1 Urenco Corporation Information
5.13.2 Urenco Description, Business Overview
5.13.3 Urenco Medical Isotopes Products Offered
5.13.4 Urenco Medical Isotopes Revenue and Gross Margin (2020-2025)
5.13.5 Urenco Medical Isotopes Revenue by Product in 2024
5.13.6 Urenco Medical Isotopes Revenue by Application in 2024
5.13.7 Urenco Medical Isotopes Revenue by Geographic Area in 2024
5.13.8 Urenco Recent Developments
5.14 LANL
5.14.1 LANL Corporation Information
5.14.2 LANL Description, Business Overview
5.14.3 LANL Medical Isotopes Products Offered
5.14.4 LANL Medical Isotopes Revenue and Gross Margin (2020-2025)
5.14.5 LANL Medical Isotopes Revenue by Product in 2024
5.14.6 LANL Medical Isotopes Revenue by Application in 2024
5.14.7 LANL Medical Isotopes Revenue by Geographic Area in 2024
5.14.8 LANL Recent Developments
5.15 Shanghai Engineering Research Center
5.15.1 Shanghai Engineering Research Center Corporation Information
5.15.2 Shanghai Engineering Research Center Description, Business Overview
5.15.3 Shanghai Engineering Research Center Medical Isotopes Products Offered
5.15.4 Shanghai Engineering Research Center Medical Isotopes Revenue and Gross Margin (2020-2025)
5.15.5 Shanghai Engineering Research Center Medical Isotopes Revenue by Product in 2024
5.15.6 Shanghai Engineering Research Center Medical Isotopes Revenue by Application in 2024
5.15.7 Shanghai Engineering Research Center Medical Isotopes Revenue by Geographic Area in 2024
5.15.8 Shanghai Engineering Research Center Recent Developments
5.16 IDB Holland
5.16.1 IDB Holland Corporation Information
5.16.2 IDB Holland Description, Business Overview
5.16.3 IDB Holland Medical Isotopes Products Offered
5.16.4 IDB Holland Medical Isotopes Revenue and Gross Margin (2020-2025)
5.16.5 IDB Holland Medical Isotopes Revenue by Product in 2024
5.16.6 IDB Holland Medical Isotopes Revenue by Application in 2024
5.16.7 IDB Holland Medical Isotopes Revenue by Geographic Area in 2024
5.16.8 IDB Holland Recent Developments
5.17 NHTC
5.17.1 NHTC Corporation Information
5.17.2 NHTC Description, Business Overview
5.17.3 NHTC Medical Isotopes Products Offered
5.17.4 NHTC Medical Isotopes Revenue and Gross Margin (2020-2025)
5.17.5 NHTC Medical Isotopes Revenue by Product in 2024
5.17.6 NHTC Medical Isotopes Revenue by Application in 2024
5.17.7 NHTC Medical Isotopes Revenue by Geographic Area in 2024
5.17.8 NHTC Recent Developments
5.18 Linde
5.18.1 Linde Corporation Information
5.18.2 Linde Description, Business Overview
5.18.3 Linde Medical Isotopes Products Offered
5.18.4 Linde Medical Isotopes Revenue and Gross Margin (2020-2025)
5.18.5 Linde Medical Isotopes Revenue by Product in 2024
5.18.6 Linde Medical Isotopes Revenue by Application in 2024
5.18.7 Linde Medical Isotopes Revenue by Geographic Area in 2024
5.18.8 Linde Recent Developments
5.19 ORNL
5.19.1 ORNL Corporation Information
5.19.2 ORNL Description, Business Overview
5.19.3 ORNL Medical Isotopes Products Offered
5.19.4 ORNL Medical Isotopes Revenue and Gross Margin (2020-2025)
5.19.5 ORNL Medical Isotopes Revenue by Product in 2024
5.19.6 ORNL Medical Isotopes Revenue by Application in 2024
5.19.7 ORNL Medical Isotopes Revenue by Geographic Area in 2024
5.19.8 ORNL Recent Developments
5.20 SI Science
5.20.1 SI Science Corporation Information
5.20.2 SI Science Description, Business Overview
5.20.3 SI Science Medical Isotopes Products Offered
5.20.4 SI Science Medical Isotopes Revenue and Gross Margin (2020-2025)
5.20.5 SI Science Medical Isotopes Revenue by Product in 2024
5.20.6 SI Science Medical Isotopes Revenue by Application in 2024
5.20.7 SI Science Medical Isotopes Revenue by Geographic Area in 2024
5.20.8 SI Science Recent Developments
6 North America
6.1 North America Medical Isotopes Market Size YoY Growth 2020-2031
6.2 North America Medical Isotopes Market Facts & Figures by Country (2020-2031)
6.3 North America Medical Isotopes Revenue by Type (2020-2025)
6.4 North America Medical Isotopes Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Medical Isotopes Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Medical Isotopes Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Medical Isotopes Revenue by Type (2020-2025)
7.4 Asia-Pacific Medical Isotopes Revenue by Application (2020-2025)
8 Europe
8.1 Europe Medical Isotopes Market Size YoY Growth 2020-2031
8.2 Europe Medical Isotopes Market Facts & Figures by Country (2020-2031)
8.3 Europe Medical Isotopes Revenue by Type (2020-2025)
8.4 Europe Medical Isotopes Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Medical Isotopes Market Size YoY Growth 2020-2031
9.2 Latin America Medical Isotopes Market Facts & Figures by Country (2020-2031)
9.3 Latin America Medical Isotopes Revenue by Type (2020-2025)
9.4 Latin America Medical Isotopes Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Medical Isotopes Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Medical Isotopes Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Medical Isotopes Revenue by Type (2020-2025)
10.4 Middle East and Africa Medical Isotopes Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Medical Isotopes Supply Chain Analysis
11.2 Medical Isotopes Key Raw Materials and Upstream Suppliers
11.3 Medical Isotopes Clients Analysis
11.4 Medical Isotopes Sales Channel and Sales Model Analysis
11.4.1 Medical Isotopes Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Medical Isotopes Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Medical Isotopes Distributors
12 Medical Isotopes Market Dynamics
12.1 Medical Isotopes Industry Trends
12.2 Medical Isotopes Market Drivers
12.3 Medical Isotopes Market Challenges
12.4 Medical Isotopes Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Medical Isotopes Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Medical Isotopes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Medical Isotopes Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Medical Isotopes Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Medical Isotopes Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Medical Isotopes Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Medical Isotopes Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Medical Isotopes Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Medical Isotopes Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Medical Isotopes Revenue by Company (2020-2025) & (US$ Million)
Table 11. Medical Isotopes Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Medical Isotopes Players by Revenue (US$ Million) in 2024
Table 13. Global Medical Isotopes Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Medical Isotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Isotopes as of 2024)
Table 15. Global Medical Isotopes Companies Headquarters
Table 16. Date of International Companies Enter into Medical Isotopes Market
Table 17. Global Medical Isotopes Companies Product & Service
Table 18. Global Medical Isotopes Mergers & Acquisitions, Expansion Plans
Table 19. NRG Corporation Information
Table 20. NRG Description and Business Overview
Table 21. NRG Medical Isotopes Product
Table 22. NRG Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. NRG Revenue Proportion of Medical Isotopes by Product in 2024
Table 24. NRG Revenue Proportion of Medical Isotopes by Application in 2024
Table 25. NRG Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 26. NRG Recent Developments
Table 27. NTP Radioisotopes Corporation Information
Table 28. NTP Radioisotopes Description and Business Overview
Table 29. NTP Radioisotopes Medical Isotopes Product
Table 30. NTP Radioisotopes Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. NTP Radioisotopes Revenue Proportion of Medical Isotopes by Product in 2024
Table 32. NTP Radioisotopes Revenue Proportion of Medical Isotopes by Application in 2024
Table 33. NTP Radioisotopes Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 34. NTP Radioisotopes Recent Developments
Table 35. JSC Isotope Corporation Information
Table 36. JSC Isotope Description and Business Overview
Table 37. JSC Isotope Medical Isotopes Product
Table 38. JSC Isotope Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. JSC Isotope Revenue Proportion of Medical Isotopes by Product in 2024
Table 40. JSC Isotope Revenue Proportion of Medical Isotopes by Application in 2024
Table 41. JSC Isotope Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 42. JSC Isotope Recent Developments
Table 43. ANSTO Corporation Information
Table 44. ANSTO Description and Business Overview
Table 45. ANSTO Medical Isotopes Product
Table 46. ANSTO Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. ANSTO Revenue Proportion of Medical Isotopes by Product in 2024
Table 48. ANSTO Revenue Proportion of Medical Isotopes by Application in 2024
Table 49. ANSTO Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 50. ANSTO Recent Developments
Table 51. IRE Corporation Information
Table 52. IRE Description and Business Overview
Table 53. IRE Medical Isotopes Product
Table 54. IRE Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. IRE Revenue Proportion of Medical Isotopes by Product in 2024
Table 56. IRE Revenue Proportion of Medical Isotopes by Application in 2024
Table 57. IRE Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 58. IRE Recent Developments
Table 59. Nordion Corporation Information
Table 60. Nordion Description and Business Overview
Table 61. Nordion Medical Isotopes Product
Table 62. Nordion Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Nordion Revenue Proportion of Medical Isotopes by Product in 2024
Table 64. Nordion Revenue Proportion of Medical Isotopes by Application in 2024
Table 65. Nordion Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 66. Nordion Recent Developments
Table 67. Curium Pharma Corporation Information
Table 68. Curium Pharma Description and Business Overview
Table 69. Curium Pharma Medical Isotopes Product
Table 70. Curium Pharma Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Curium Pharma Revenue Proportion of Medical Isotopes by Product in 2024
Table 72. Curium Pharma Revenue Proportion of Medical Isotopes by Application in 2024
Table 73. Curium Pharma Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 74. Curium Pharma Recent Developments
Table 75. Cambridge Isotope Laboratories Corporation Information
Table 76. Cambridge Isotope Laboratories Description and Business Overview
Table 77. Cambridge Isotope Laboratories Medical Isotopes Product
Table 78. Cambridge Isotope Laboratories Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Cambridge Isotope Laboratories Revenue Proportion of Medical Isotopes by Product in 2024
Table 80. Cambridge Isotope Laboratories Revenue Proportion of Medical Isotopes by Application in 2024
Table 81. Cambridge Isotope Laboratories Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 82. Cambridge Isotope Laboratories Recent Developments
Table 83. Eckert & Ziegler Strahlen Corporation Information
Table 84. Eckert & Ziegler Strahlen Description and Business Overview
Table 85. Eckert & Ziegler Strahlen Medical Isotopes Product
Table 86. Eckert & Ziegler Strahlen Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Eckert & Ziegler Strahlen Revenue Proportion of Medical Isotopes by Product in 2024
Table 88. Eckert & Ziegler Strahlen Revenue Proportion of Medical Isotopes by Application in 2024
Table 89. Eckert & Ziegler Strahlen Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 90. Eckert & Ziegler Strahlen Recent Developments
Table 91. Polatom Corporation Information
Table 92. Polatom Description and Business Overview
Table 93. Polatom Medical Isotopes Product
Table 94. Polatom Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Polatom Revenue Proportion of Medical Isotopes by Product in 2024
Table 96. Polatom Revenue Proportion of Medical Isotopes by Application in 2024
Table 97. Polatom Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 98. Polatom Recent Developments
Table 99. Center of Molecular Research Corporation Information
Table 100. Center of Molecular Research Description and Business Overview
Table 101. Center of Molecular Research Medical Isotopes Product
Table 102. Center of Molecular Research Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Center of Molecular Research Revenue Proportion of Medical Isotopes by Product in 2024
Table 104. Center of Molecular Research Revenue Proportion of Medical Isotopes by Application in 2024
Table 105. Center of Molecular Research Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 106. Center of Molecular Research Recent Developments
Table 107. China National Nuclear Corporation Corporation Information
Table 108. China National Nuclear Corporation Description and Business Overview
Table 109. China National Nuclear Corporation Medical Isotopes Product
Table 110. China National Nuclear Corporation Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. China National Nuclear Corporation Revenue Proportion of Medical Isotopes by Product in 2024
Table 112. China National Nuclear Corporation Revenue Proportion of Medical Isotopes by Application in 2024
Table 113. China National Nuclear Corporation Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 114. China National Nuclear Corporation Recent Developments
Table 115. Urenco Corporation Information
Table 116. Urenco Description and Business Overview
Table 117. Urenco Medical Isotopes Product
Table 118. Urenco Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Urenco Revenue Proportion of Medical Isotopes by Product in 2024
Table 120. Urenco Revenue Proportion of Medical Isotopes by Application in 2024
Table 121. Urenco Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 122. Urenco Recent Developments
Table 123. LANL Corporation Information
Table 124. LANL Description and Business Overview
Table 125. LANL Medical Isotopes Product
Table 126. LANL Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. LANL Revenue Proportion of Medical Isotopes by Product in 2024
Table 128. LANL Revenue Proportion of Medical Isotopes by Application in 2024
Table 129. LANL Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 130. LANL Recent Developments
Table 131. Shanghai Engineering Research Center Corporation Information
Table 132. Shanghai Engineering Research Center Description and Business Overview
Table 133. Shanghai Engineering Research Center Medical Isotopes Product
Table 134. Shanghai Engineering Research Center Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Shanghai Engineering Research Center Revenue Proportion of Medical Isotopes by Product in 2024
Table 136. Shanghai Engineering Research Center Revenue Proportion of Medical Isotopes by Application in 2024
Table 137. Shanghai Engineering Research Center Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 138. Shanghai Engineering Research Center Recent Developments
Table 139. IDB Holland Corporation Information
Table 140. IDB Holland Description and Business Overview
Table 141. IDB Holland Medical Isotopes Product
Table 142. IDB Holland Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. IDB Holland Revenue Proportion of Medical Isotopes by Product in 2024
Table 144. IDB Holland Revenue Proportion of Medical Isotopes by Application in 2024
Table 145. IDB Holland Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 146. IDB Holland Recent Developments
Table 147. NHTC Corporation Information
Table 148. NHTC Description and Business Overview
Table 149. NHTC Medical Isotopes Product
Table 150. NHTC Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. NHTC Revenue Proportion of Medical Isotopes by Product in 2024
Table 152. NHTC Revenue Proportion of Medical Isotopes by Application in 2024
Table 153. NHTC Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 154. NHTC Recent Developments
Table 155. Linde Corporation Information
Table 156. Linde Description and Business Overview
Table 157. Linde Medical Isotopes Product
Table 158. Linde Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Linde Revenue Proportion of Medical Isotopes by Product in 2024
Table 160. Linde Revenue Proportion of Medical Isotopes by Application in 2024
Table 161. Linde Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 162. Linde Recent Developments
Table 163. ORNL Corporation Information
Table 164. ORNL Description and Business Overview
Table 165. ORNL Medical Isotopes Product
Table 166. ORNL Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. ORNL Revenue Proportion of Medical Isotopes by Product in 2024
Table 168. ORNL Revenue Proportion of Medical Isotopes by Application in 2024
Table 169. ORNL Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 170. ORNL Recent Developments
Table 171. SI Science Corporation Information
Table 172. SI Science Description and Business Overview
Table 173. SI Science Medical Isotopes Product
Table 174. SI Science Medical Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. SI Science Revenue Proportion of Medical Isotopes by Product in 2024
Table 176. SI Science Revenue Proportion of Medical Isotopes by Application in 2024
Table 177. SI Science Revenue Proportion of Medical Isotopes by Geographic Area in 2024
Table 178. SI Science Recent Developments
Table 179. North America Medical Isotopes Revenue by Country (2020-2025) & (US$ Million)
Table 180. North America Medical Isotopes Revenue by Country (2026-2031) & (US$ Million)
Table 181. North America Medical Isotopes Revenue by Type (2020-2025) & (US$ Million)
Table 182. North America Medical Isotopes Revenue by Application (2020-2025) & (US$ Million)
Table 183. Asia-Pacific Medical Isotopes Revenue by Region (2020-2025) & (US$ Million)
Table 184. Asia-Pacific Medical Isotopes Revenue by Region (2026-2031) & (US$ Million)
Table 185. Asia-Pacific Medical Isotopes Revenue by Type (2020-2025) & (US$ Million)
Table 186. Asia-Pacific Medical Isotopes Revenue by Application (2020-2025) & (US$ Million)
Table 187. Europe Medical Isotopes Revenue by Country (2020-2025) & (US$ Million)
Table 188. Europe Medical Isotopes Revenue by Country (2026-2031) & (US$ Million)
Table 189. Europe Medical Isotopes Revenue by Type (2020-2025) & (US$ Million)
Table 190. Europe Medical Isotopes Revenue by Application (2020-2025) & (US$ Million)
Table 191. Latin America Medical Isotopes Revenue by Country (2020-2025) & (US$ Million)
Table 192. Latin America Medical Isotopes Revenue by Country (2026-2031) & (US$ Million)
Table 193. Latin America Medical Isotopes Revenue by Type (2020-2025) & (US$ Million)
Table 194. Latin America Medical Isotopes Revenue by Application (2020-2025) & (US$ Million)
Table 195. Middle East and Africa Medical Isotopes Revenue by Country (2020-2025) & (US$ Million)
Table 196. Middle East and Africa Medical Isotopes Revenue by Country (2026-2031) & (US$ Million)
Table 197. Middle East and Africa Medical Isotopes Revenue by Type (2020-2025) & (US$ Million)
Table 198. Middle East and Africa Medical Isotopes Revenue by Application (2020-2025) & (US$ Million)
Table 199. Medical Isotopes Key Raw Materials, Industry Status and Trend
Table 200. Medical Isotopes Key Raw Materials and Upstream Suppliers
Table 201. Medical Isotopes Clients Status and Trend
Table 202. Medical Isotopes Typical Clients
Table 203. Medical Isotopes Distributors
Table 204. Medical Isotopes Market Trends
Table 205. Medical Isotopes Market Drivers
Table 206. Medical Isotopes Market Challenges
Table 207. Medical Isotopes Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Isotopes Product Picture
Figure 2. Global Medical Isotopes Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Medical Isotopes Revenue Market Share by Type in 2024 & 2031
Figure 4. Stable Isotopes Product Picture
Figure 5. Radioisotopes Product Picture
Figure 6. Global Medical Isotopes Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Medical Isotopes Revenue Market Share by Application in 2024 & 2031
Figure 8. Nuclear Therapy
Figure 9. Equipment Radioactive Source
Figure 10. Diagnosis
Figure 11. Medical Isotopes Report Years Considered
Figure 12. Global Medical Isotopes Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Medical Isotopes Market Size (2020-2031) & (US$ Million)
Figure 14. Global Medical Isotopes Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Medical Isotopes Revenue Market Share by Region (2020-2031)
Figure 16. Global Medical Isotopes Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Medical Isotopes Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Stable Isotopes of Medical Isotopes Revenue Market Share by Application, 2024 VS 2031
Figure 19. Radioisotopes of Medical Isotopes Revenue Market Share by Application, 2024 VS 2031
Figure 20. Medical Isotopes Revenue Share by Company (2024)
Figure 21. Medical Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Stable Isotopes Revenue Proportion by Company in 2024
Figure 23. Radioisotopes Revenue Proportion by Company in 2024
Figure 24. North America Medical Isotopes Revenue 2020-2031 (US$ Million)
Figure 25. North America Medical Isotopes Revenue Market Share by Type (2020-2025)
Figure 26. North America Medical Isotopes Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Medical Isotopes Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Medical Isotopes Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Medical Isotopes Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Medical Isotopes Revenue Market Share by Application (2020-2025)
Figure 31. Europe Medical Isotopes Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Medical Isotopes Revenue Market Share by Country (2020-2031)
Figure 33. Europe Medical Isotopes Revenue Market Share by Type (2020-2025)
Figure 34. Europe Medical Isotopes Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Medical Isotopes Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Medical Isotopes Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Medical Isotopes Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Medical Isotopes Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Medical Isotopes Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Medical Isotopes Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Medical Isotopes Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Medical Isotopes Revenue Market Share by Application (2020-2025)
Figure 43. Medical Isotopes Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Medical Isotopes Raw Materials by Region in 2024
Figure 45. Medical Isotopes Distribution Channels
Figure 46. Global Medical Isotopes Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Medical Isotopes Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
